心肺运动试验检测系统性硬化相关肺动脉高压
该多中心前瞻性研究纳入173例临床怀疑肺动脉高压的系统性硬化患者,均行心肺运动试验和右心导管检查。右心导管确诊肺动脉高压48例(27.8%),峰值摄氧量诊断准确率最高(阈值13.8 mL/min/kg时敏感度87.5%、特异度74.8%),峰值摄氧量>18.7 mL/kg/min可排除肺动脉高压(阴性预测值1.0)。
要点
- 峰值摄氧量阈值13.8 mL/min/kg诊断肺动脉高压敏感度87.5%、特异度74.8%。
- 峰值摄氧量>18.7 mL/kg/min阴性预测值1.0,可排除肺动脉高压。
- 最低通气当量比值>45.5阳性预测值1.0;肺毛细血管楔压<12 mm Hg者诊断准确率最高。
核心结论
- 心肺运动试验是安全且有价值的无创检测系统性硬化相关肺动脉高压的方法,可能特别有助于减少不必要的右心导管检查。
研究设计与样本
- 多中心前瞻性研究,连续纳入173例已知无肺动脉高压但临床怀疑肺动脉高压的系统性硬化患者,每例均行心肺运动试验和右心导管检查。
主要发现
- 右心导管确诊肺动脉高压48例(27.8%),毛细血管后肺动脉高压10例(5.8%),排除肺动脉高压115例(66.5%)。
- 心肺运动试验参数与肺动脉血流动力学显著相关,峰值摄氧量和通气当量比值与肺动脉压、跨肺压差及肺血管阻力相关性最高。
- 峰值摄氧量诊断准确率最高(阈值13.8 mL/min/kg时敏感度87.5%、特异度74.8%)。
- 峰值摄氧量>18.7 mL/kg/min者38/173例(22%),在该队列中排除肺动脉高压(阴性预测值1.0)。
- 最低通气当量比值>45.5的阳性预测值为1.0;肺毛细血管楔压<12 mm Hg者诊断准确率最高。
关键数值与推荐
- 峰值摄氧量阈值13.8 mL/min/kg:敏感度87.5%、特异度74.8%。
- 峰值摄氧量>18.7 mL/kg/min:阴性预测值1.0。
- 最低通气当量比值>45.5:阳性预测值1.0。
- 肺毛细血管楔压<12 mm Hg者诊断准确率最高。
临床怎么用
- 心肺运动试验是安全且有价值的无创检测系统性硬化相关肺动脉高压的方法,可能特别有助于减少不必要的右心导管检查。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Pulmonary arterial hypertension (PAH) is a devastating disease with limited survival and occurs as a frequent complication in patients with systemic sclerosis (SSc). A definite diagnosis of PAH is obtained by right heart catheterisation (RHC); however, the initial suspicion is raised by non-invasive methods. We assessed the diagnostic accuracy of key parameters derived from cardiopulmonary exercise testing (CPET) for detecting and ruling out SSc-associated PAH. METHODS: In a multicentre setting, we prospectively evaluated 173 consecutive patients with SSc without known PAH, but with clinical suspicion of PAH. Each patient underwent CPET and RHC. RESULTS: RHC identified PAH in 48 patients (27.8%), postcapillary pulmonary hypertension (PH) in 10 patients (5.8%) and ruled out PH in 115 patients (66.5%). CPET parameters correlated significantly with pulmonary haemodynamics. PeakVO2 and VE/VCO2 showed highest correlations with pulmonary arterial pressure, transpulmonary pressure gradient and pulmonary vascular resistance. Several parameters showed high sensitivity and specificity for PAH detection by receiver operating characteristic analysis. However, peakVO2 showed highest diagnostic accuracy (sensitivity 87.5%, specificity 74.8% at a threshold level of 13.8 mL/min/kg). A peakVO2 of >18.7 mL/kg/min was reached by 38/173 patients (22%) and excluded PAH in our cohort (negative predictive value 1.0). A nadir VE/VCO2 ratio of >45.5 showed a positive predictive value of 1.0. Diagnostic accuracy was highest in patients with low pulmonary arterial wedge pressure (<12 mm Hg). There were no study-related serious adverse events. CONCLUSIONS: CPET is a safe and valuable method in the non-invasive detection of SSc-associated PAH. It may be particularly beneficial for reducing unnecessary RHC procedures.
引用
- Dumitrescu D, Nagel C, Kovacs G, et al. Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis. Heart. 2017. PMID: 28062514. doi:10.1136/heartjnl-2016-309981
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。